pcDNA3.1 HA-rnSOX9 Citations (2)

Originally described in: SOX9 inhibits beta-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
Deng W, Vanderbilt DB, Lin CC, Martin KH, Brundage KM, Ruppert JM J Cell Sci. 2015 Jan 27. pii: jcs.162164. PubMed Journal

---

Articles Citing pcDNA3.1 HA-rnSOX9

Articles
Sublytic C5b-9 induces glomerular mesangial cell proliferation via ERK1/2-dependent SOX9 phosphorylation and acetylation by enhancing Cyclin D1 in rat Thy-1 nephritis. Xie M, Wu Z, Ying S, Liu L, Zhao C, Yao C, Zhang Z, Luo C, Wang W, Zhao D, Zhang J, Qiu W, Wang Y. Exp Mol Med. 2021 Apr;53(4):572-590. doi: 10.1038/s12276-021-00589-9. Epub 2021 Apr 2. PubMed
Transcription regulators differentiate mesenchymal stem cells into chondroprogenitors, and their in vivo implantation regenerated the intervertebral disc degeneration. Khalid S, Ekram S, Salim A, Chaudhry GR, Khan I. World J Stem Cells. 2022 Feb 26;14(2):163-182. doi: 10.4252/wjsc.v14.i2.163. PubMed

If you have published an article using this material, please email us at to have your article added to this page.